RG
Redmile Group’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Sell |
1,423,411
-186,918
| -12% | -$3.18M | 2.58% | 13 |
|
|
2025
Q1 | $31.4M | Buy |
1,610,329
+81,762
| +5% | +$1.6M | 2.97% | 11 |
|
|
2024
Q4 | $37.9M | Sell |
1,528,567
-82,446
| -5% | -$2.04M | 2.64% | 12 |
|
|
2024
Q3 | $39.5M | Sell |
1,611,013
-92,048
| -5% | -$2.26M | 2.33% | 19 |
|
|
2024
Q2 | $39.9M | Sell |
1,703,061
-176,556
| -9% | -$4.14M | 2.41% | 15 |
|
|
2024
Q1 | $62.1M | Buy |
1,879,617
+449,834
| +31% | +$14.9M | 2.28% | 14 |
|
|
2023
Q4 | $38.9M | Sell |
1,429,783
-39,942
| -3% | -$1.09M | 1.39% | 23 |
|
|
2023
Q3 | $35.3M | Sell |
1,469,725
-15,474
| -1% | -$372K | 1.68% | 19 |
|
|
2023
Q2 | $47.4M | Sell |
1,485,199
-126,895
| -8% | -$4.05M | 1.82% | 15 |
|
|
2023
Q1 | $49.4M | Sell |
1,612,094
-158,493
| -9% | -$4.85M | 2.14% | 14 |
|
|
2022
Q4 | $69.2M | Sell |
1,770,587
-2,400
| -0.1% | -$93.9K | 2.83% | 10 |
|
|
2022
Q3 | $84.5M | Sell |
1,772,987
-76,900
| -4% | -$3.66M | 3.28% | 7 |
|
|
2022
Q2 | $71.6M | Buy |
1,849,887
+13,837
| +0.8% | +$536K | 2.73% | 8 |
|
|
2022
Q1 | $105M | Sell |
1,836,050
-49,800
| -3% | -$2.85M | 3.28% | 9 |
|
|
2021
Q4 | $150M | Sell |
1,885,850
-89,156
| -5% | -$7.1M | 3.42% | 8 |
|
|
2021
Q3 | $172M | Sell |
1,975,006
-77,500
| -4% | -$6.74M | 3% | 9 |
|
|
2021
Q2 | $264M | Sell |
2,052,506
-480,017
| -19% | -$61.8M | 3.91% | 3 |
|
|
2021
Q1 | $203M | Sell |
2,532,523
-1,245,739
| -33% | -$99.7M | 2.86% | 6 |
|
|
2020
Q4 | $308M | Buy |
3,778,262
+451,000
| +14% | +$36.8M | 3.74% | 4 |
|
|
2020
Q3 | $81.9M | Sell |
3,327,262
-29,696
| -0.9% | -$731K | 1.5% | 21 |
|
|
2020
Q2 | $94M | Sell |
3,356,958
-2,300
| -0.1% | -$64.4K | 1.74% | 16 |
|
|
2020
Q1 | $60.5M | Buy |
+3,359,258
| New | +$60.5M | 1.7% | 17 |
|